Hofseth BioCare ASA
James Berger has a diverse work experience in the financial industry. James is currently the Chief Commercial Officer at Hofseth BioCare ASA since October 2019. Before that, they founded Nevera AG in October 2019, where they provided financial consulting services primarily for listed equities, capital raising, and corporate communications. James also served as the Chief Executive Officer at Nevera AG.
Prior to their roles at Nevera AG and Hofseth BioCare ASA, James worked as a Portfolio Manager at Millennium Management from March 2017 to July 2019. James was also the Chief Investment Officer at B1 Capital AG from April 2013 to December 2015.
In earlier stages of their career, James held positions at GLG Partners as a Fund Manager from January 2007 to September 2012, at J.P. Morgan as a Vice President from March 2005 to January 2007, and at Goldman Sachs as an Associate from June 2001 to March 2005.
James Berger attended the University of Cambridge from 1998 to 2001, where they pursued a degree in Land Economy, with a focus on Economics and Law.
This person is not in any offices
Hofseth BioCare ASA
Hofseth BioCare´s key objective is to provide high value added biomarine ingredients for human applications. Through innovative production technology and logistics, they preserve the quality of protein, calcium and oil extracted from fish. This technology is proprietary to their company.